4.8 Letter

Is HCV RNA analysis at day 7 cost-effective in deciding the duration of therapy in chronic HCV genotype 2/3 infection?

Journal

JOURNAL OF HEPATOLOGY
Volume 54, Issue 4, Pages 835-836

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jhep.2010.09.038

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

The HLA-B-21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia

Alexander Hallner, Elin Bernson, Brwa Ali Hussein, Frida Ewald Sander, Mats Brune, Johan Aurelius, Anna Martner, Kristoffer Hellstrand, Fredrik B. Thoren

BLOOD (2019)

Article Biochemistry & Molecular Biology

NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease

Ebru Aydin, Alexander Hallner, Hanna Grauers Wiktorin, Anna Staffas, Kristoffer Hellstrand, Anna Martner

ONCOGENE (2019)

Article Multidisciplinary Sciences

No need to discontinue hepatitis C virus therapy at the time of liver transplantation

Catarina Skoglund, Martin Lagging, Maria Castedal

PLOS ONE (2019)

Article Oncology

Anthracycline-based consolidation may determine outcome of post-consolidation immunotherapy in AML

Johan Aurelius, Lars Mollgard, Roberta Kiffin, Frida Ewald Sander, Staffan Nilsson, Fredrik Bergh Thoren, Kristoffer Hellstrand, Anna Martner

LEUKEMIA & LYMPHOMA (2019)

Article Clinical Neurology

Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study

Jonas Soderholm, Aylin Yilmaz, Anders Svenningsson, Katharina Busch, Rune Wejstal, Alma Brolund, Jan Kovamees, Matti Sallberg, Martin Lagging, Magnus Gisslen

JOURNAL OF NEUROLOGY (2019)

Article Biotechnology & Applied Microbiology

Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype

Malin S. Nilsson, Alexander Hallner, Mats Brune, Staffan Nilsson, Fredrik B. Thoren, Anna Martner, Kristoffer Hellstrand

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)

Letter Hematology

Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse-preventive immunotherapy in acute myeloid leukaemia

Malin S. Nilsson, Alexander Hallner, Mats Brune, Staffan Nilsson, Fredrik B. Thoren, Anna Martner, Kristoffer Hellstrand

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Article Multidisciplinary Sciences

The relation of 25-hydroxy vitamin D concentrations to liver histopathology, seasonality and baseline characteristics in chronic hepatitis C virus genotype 2 or 3 infection

Jesper Waldenstrom, Kristina Nystrom, Staffan Nilsson, Gunnar Norkrans, Magdalena Ydreborg, Nina Langeland, Kristine Morch, Johan Westin, Martin Lagging

PLOS ONE (2020)

Article Gastroenterology & Hepatology

Presence of interferon-λ, 4, male vender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus

Jesper Waldenstrom, Kristoffer Hellstrand, Johan Westin, Staffan Nilsson, Peer Christensen, Martti Farkkila, Kristine Morch, Nina Langeland, Gunnar Norkrans, Martin Lagging

Summary: The study indicates that patients who can produce IFN-lambda 4, along with male gender, milder steatosis, and lower viral load, have higher levels of antibodies against HCV. This suggests that IFN-lambda 4 may be associated with Th2 immune skewing and could have clinical implications beyond HCV infection.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection

Jesper Waldenstrom, Martin Kaberg, Marianne Alanko Blome, Anders Widell, Per Bjorkman, Staffan Nilsson, Anders Hammarberg, Ola Weiland, Kristina Nystrom, Martin Lagging

Summary: The absence of IFN-lambda 4 increases the likelihood of spontaneous resolution of acute HCV infections, especially for individuals who have been repeatedly exposed to HCV. ITPase genetic variants do not independently impact outcomes, but in males lacking IFN-lambda 4, reduced ITPase activity significantly improves the likelihood of virus clearance.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Clinical Neurology

Impact of CYBA genotypes on severity and progression of multiple sclerosis

Andreas Tornell, Roberta Kiffin, Sara Haghighi, Natalia Mossberg, Oluf Andersen, Kristoffer Hellstrand, Anna Martner

Summary: This study found that genetic variations within the CYBA gene, which affects the formation of reactive oxygen species (ROS), are associated with the severity and progression of multiple sclerosis (MS). Specifically, low-ROS alleles were linked to reduced MS severity and delayed onset of secondary progressive MS (SPMS). These findings suggest that targeting the NOX2 enzyme may be a potential therapeutic strategy to delay secondary progression in MS.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Multidisciplinary Sciences

Transient and durable T cell reactivity after COVID-19

Anna Martner, Hanna Grauers Wiktorin, Andreas Tornell, Johan Ringlander, Mohammad Arabpour, Magnus Lindh, Martin Lagging, Staffan Nilsson, Kristoffer Hellstrand

Summary: This study identified two phases of T cell reactivity in COVID-19 patients: an early transient response and a durable cell memory.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Infectious Diseases

Catch-up antibody responses and hybrid immunity in mRNA vaccinated patients at risk of severe COVID-19

Samer Al-Dury, Jesper Waldenstrom, Johan Ringlander, Sigrun Einarsdottir, Markus Andersson, Hevar Hamah Saed, Johan Waern, Anna Martner, Kristoffer Hellstrand, Martin Lagging

Summary: This study investigated the impact of repeated vaccination and hybrid immunity on antibody levels in immunosuppressed patients. The results showed that immunosuppressed patients achieved antibody levels comparable to controls after receiving three doses of the vaccine. Hybrid immunity resulted in approximately 10-fold higher antibody levels than vaccine-induced immunity alone in all study cohorts.

INFECTIOUS DISEASES (2023)

No Data Available